Frovatriptan and data publication

Headache

Volumn 48, Issue 9, 2008, Pages 1382-1383

  Tfelt Hansen, Peer ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FROVATRIPTAN; PLACEBO; SUMATRIPTAN;

CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; HEADACHE; HUMAN; LETTER; MIGRAINE; PRIORITY JOURNAL; PUBLICATION; TREATMENT RESPONSE;

CARBAZOLES; DOUBLE-BLIND METHOD; HUMANS; MIGRAINE DISORDERS; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN AGONISTS; SUMATRIPTAN; TRYPTAMINES;

EID: 53849115032     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01244.x     Document Type: Letter

References (7)

1. Tfelt-Hansen P. Frovatriptan. Headache. 2007 47 : 934.
2. Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002 47 (Suppl. 2 S93 S99.
3. Rothrock JF. Frovatriptan. Headache. 2007 47 : 934.
4. Hutchison J, Pfaffenrath V, Geraud G. A randomized, placebo-controlled, parallel-group trial of frovatriptan and sumatriptan for a single acute migraine attack. Eur J Neurol. 2007 14 (Suppl. 1 144.
5. International Headache Society Clinical Trial Subcommittee. Guidelines for controlled trials of drugs in migraine, second edn. Cephalalgia. 2000 20 : 765 786.
6. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine. A comparative review of pharmacology, pharmacokinetics and efficacy. Drugs. 2000 60 : 1259 1287.
7. 1B/!D agonists) in acute migraine: A meta-analysis of 53 trials. Lancet. 2001 358 : 1668 1675.